S889-0051 Screening compound: (1S,10R)-5-methyl-13-[2-(1H-1,2,3,4-tetraazol-1-yl)acetyl]-4,6,13-triazatricyclo[8.2.1.0~3,8~]trideca-3(8),4-dien-7-one

S889-0051 Screening compound: (1S,10R)-5-methyl-13-[2-(1H-1,2,3,4-tetraazol-1-yl)acetyl]-4,6,13-triazatricyclo[8.2.1.0~3,8~]trideca-3(8),4-dien-7-one
S889-0051 Screening compound: (1S,10R)-5-methyl-13-[2-(1H-1,2,3,4-tetraazol-1-yl)acetyl]-4,6,13-triazatricyclo[8.2.1.0~3,8~]trideca-3(8),4-dien-7-one alternative view

Chemical Structure Depiction of ChemDiv screening compound S889-0051
(1S,10R)-5-methyl-13-[2-(1H-1,2,3,4-tetraazol-1-yl)acetyl]-4,6,13-triazatricyclo[8.2.1.0~3,8~]trideca-3(8),4-dien-7-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

S889-0051

Molecular Formula

C14H17N7O2 (C14 H17 N7 O2)

Compound Name

(1S,10R)-5-methyl-13-[2-(1H-1,2,3,4-tetraazol-1-yl)acetyl]-4,6,13-triazatricyclo[8.2.1.0~3,8~]trideca-3(8),4-dien-7-one

IUPAC name

(1S10R)-5-methyl-13-[2-(1H-1234-tetrazol-1-yl)acetyl]-4613-triazatricyclo[8.2.1.0^{38}]trideca-3(8)4-dien-7-one

SMILES

CC(N1)=NC(C[C@H](CC[C@@H]2C3)N2C(Cn2nnnc2)=O)=C3C1=O

InChI

InChI=1S/C14H17N7O2/c1-8-16-12-5-10-3-2-9(4-11(12)14(23)17-8)21(10)13(22)6-20-7-15-18-19-20/h7,9-10H,2-6H2,1H3,(H,16,17,23)/t9-,10-/m1/s1

InChI Key

KYJHZVVTKJZLJH-NXEZZACHSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

315.33

Hydrogen Bond Acceptors Count

8.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

3.00

Number of Nitrogen and Oxygen Atoms

9

Partition Coefficient, logP

-1.494

Distribution Coefficient, logD

-1.496

Water Solubility, LogSw

-1.17

Polar Surface Area

89.122

Acid Dissociation Constant (pKa)

9.75

Base Dissociation Constant (pKb)

-0.44

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

57.14

S889-0051 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

RAR (Nuclear receptors) Ligands Library (6524 compounds)

Spiro Library (21655 compounds)

Beyond the Flatland Library sp3 enriched (92988 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
  • Receptor's ligands
  • PPI modulators
Structure:
  • Mimetics
  • Cyclic compounds
  • Cyclic compounds
Therapeutical areas:
  • Cancer
  • Respiratory tract
  • Eye
  • Male
  • Female
  • Hemic and lymphatic
  • Congenital
  • Skin
  • Endocrine
  • Immune system
Targets:
  • Nuclear receptors

References: we are preparing a list of scientific research reports with S889-0051 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound S889-0051?
Check Price and Availability of S889-0051, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of S889-0051 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for S889-0051
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for S889-0051
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of S889-0051 available by request